Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRT
3826
DELISTED
Startek Inc.
SRT
| $113K | ﹤0.01% |
20,447
+4,631
| +29% | +$28.5K |
|
3827
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $112K | ﹤0.01% |
+968
| New | +$111K |
|
3828
Harvard Bioscience
HBIO
$27.5M
| $112K | ﹤0.01% |
1,606
+1,087
| +209% | +$86.5K |
|
3829
First Western Financial
MYFW
$310M
| $112K | ﹤0.01% |
3,905
-764
| -16% | -$20.4K |
|
3830
Preformed Line Products
PLPC
$1.8B
| $112K | ﹤0.01% |
1,724
+818
| +90% | +$57.7K |
|
3831
Banco Santander
SAN
$202B
| $112K | ﹤0.01% |
31,025
-197,769
| -86% | -$730K |
|
3832
ProShares Ultra Dow30
DDM
$536M
| $111K | ﹤0.01% |
3,196
-2,612
| -45% | -$96.5K |
|
3833
CALL
Steel Dynamics
STLD
$36.2B
| $111K | ﹤0.01% |
1,900
| – | – |
|
3834
Westwater Resources
WWR
$52.1M
| $111K | ﹤0.01% |
30,902
+13,911
| +82% | +$54.4K |
|
|
SEI
3835
Solaris Energy Infrastructure
SEI
$3.14B
| $111K | ﹤0.01% |
13,262
+8,293
| +167% | +$67.3K |
|
|
ATNX
3836
DELISTED
Athenex, Inc. Common Stock
ATNX
| $111K | ﹤0.01% |
1,843
-1,264
| -41% | -$92K |
|
3837
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $110K | ﹤0.01% |
4,094
+2,754
| +206% | +$73.5K |
|
3838
Fortress Biotech
FBIO
$109M
| $110K | ﹤0.01% |
2,291
+1,687
| +279% | +$82.4K |
|
|
TBHC
3839
DELISTED
The Brand House Collective
TBHC
| $110K | ﹤0.01% |
5,727
-128
| -2% | -$2.53K |
|
3840
PUT
Iron Mountain
IRM
$37.1B
| $109K | ﹤0.01% |
2,500
| – | – |
|
3841
VanEck Pharmaceutical ETF
PPH
$970M
| $109K | ﹤0.01% |
1,502
-3,094
| -67% | -$231K |
|
3842
Stereotaxis
STXS
$133M
| $109K | ﹤0.01% |
20,282
+14,003
| +223% | +$106K |
|
|
GTYH
3843
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $109K | ﹤0.01% |
14,426
+8,362
| +138% | +$60K |
|
3844
Lifecore Biomedical
LFCR
$164M
| $108K | ﹤0.01% |
11,676
-4,312
| -27% | -$46.9K |
|
|
ADVM
3845
DELISTED
Adverum Biotechnologies
ADVM
| $107K | ﹤0.01% |
4,931
-968
| -16% | -$24.7K |
|
3846
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.2B
| $107K | ﹤0.01% |
1,900
| – | – |
|
3847
SAP
SAP
$209B
| $107K | ﹤0.01% |
792
-10,863
| -93% | -$1.58M |
|
|
TACO
3848
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $107K | ﹤0.01% |
12,204
+8,349
| +217% | +$73.9K |
|
3849
Pure Cycle
PCYO
$258M
| $106K | ﹤0.01% |
7,930
+5,248
| +196% | +$76K |
|
|
TWN
3850
Taiwan Fund
TWN
$462M
| $105K | ﹤0.01% |
2,980
| – | – |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.